These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11057116)

  • 21. Incidence and risk factors predictive of unstable angina resulting from restenosis after percutaneous angioplasty of saphenous vein grafts.
    Chandrasekar B; Bourassa MG
    Am Heart J; 2000 Dec; 140(6):827-33. PubMed ID: 11099984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical outcome in patients after single vessel PTCA with multiple stent implantation].
    Pieniazek P; Przewłocki T; Zmudka K; Dudek D; Sedziwy E; Olszowska M; Kostkiewicz M; Kapelak B; Tracz W
    Przegl Lek; 2001; 58(6):479-83. PubMed ID: 11816735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Following PTCA exercise tolerance is only moderately correlated with cinevideo-densitometric measurement of restenosis.
    Horner SM
    Cor Vasa; 1993; 35(1):20-3. PubMed ID: 8444036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
    Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
    Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting.
    de Cannière D; Jansens JL; Goldschmidt-Clermont P; Barvais L; Decroly P; Stoupel E
    Am Heart J; 2001 Oct; 142(4):563-70. PubMed ID: 11579343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous transluminal coronary angioplasty in the young patients--Siriraj Hospital's experience.
    Singhaviranon L; Mahanonda N; Chotinaiwattarakul C; Chirapastan A; Kwo-Sa-Ard B; Tanapibunpon P; Kanabencha A; Jaidee T; Chaithiraphan S
    J Med Assoc Thai; 2000 Nov; 83 Suppl 2():S199-205. PubMed ID: 11194015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in patients' illness representations before and after elective percutaneous transluminal coronary angioplasty.
    Astin F; Jones K
    Heart Lung; 2006; 35(5):293-300. PubMed ID: 16963361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional testing after percutaneous transluminal coronary angioplasty in Canada and the United States: a survey of practice patterns.
    Gidengil C; Garzon P; Eisenberg MJ
    Can J Cardiol; 2000 Jun; 16(6):739-46. PubMed ID: 10863165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Restenosis after percutaneous coronary angioplasty--cause, prevention strategies].
    Szyguła J; Puzio B; Poloński L
    Wiad Lek; 1998; 51(1-2):76-81. PubMed ID: 9608836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of restenosis after PTCA--a statistical problem].
    Lechleitner P
    Dtsch Med Wochenschr; 1991 May; 116(22):877. PubMed ID: 2036952
    [No Abstract]   [Full Text] [Related]  

  • 32. Can an old drug prevent restenosis after PTCA?
    Harv Heart Lett; 1998 Apr; 8(8):4-6. PubMed ID: 9549435
    [No Abstract]   [Full Text] [Related]  

  • 33. Can aggressive efforts directed at lipid lowering post-PTCA reduce the risk of restenosis?
    Drown DJ
    Prog Cardiovasc Nurs; 1995; 10(2):40. PubMed ID: 7651950
    [No Abstract]   [Full Text] [Related]  

  • 34. [Gene therapy for restenosis after angioplasty].
    Morishita R; Higaki J; Ogihara T
    Rinsho Byori; 1997 Feb; Suppl 104():224-31. PubMed ID: 9128386
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospects for gene therapy of postangioplasty restenosis.
    Steg PG; Feldman LJ
    Adv Nephrol Necker Hosp; 1997; 26():121-31. PubMed ID: 8922129
    [No Abstract]   [Full Text] [Related]  

  • 36. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.
    Lisi DM
    N Engl J Med; 1997 Dec; 337(26):1919. PubMed ID: 9417527
    [No Abstract]   [Full Text] [Related]  

  • 37. Overcommitment predicts restenosis after coronary angioplasty in cardiac patients.
    Joksimovic L; Siegrist J; Meyer-Hammer M; Peter R; Franke B; Klimek WJ; Heintzen MP; Strauer BE
    Int J Behav Med; 1999; 6(4):356-69. PubMed ID: 16250675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quality of life of patients with atherosclerotic lesion of lower extremity arteries as dependent on individual and typological properties of the patient personality].
    Martem'ianov SV; Uvarov EA; Safonova OV; Eliseev AA
    Angiol Sosud Khir; 2003; 9(4):15-9. PubMed ID: 14657905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perception of and psychological coping with medical technology. How does the patient perceive percutaneous transluminal coronary angioplasty?].
    Jordan J
    Fortschr Med; 1993 Sep; 111(25):385-8. PubMed ID: 8406283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restenosis after coronary angioplasty: pathophysiology and therapeutic implications (part 2 of two parts).
    Myler RK; Shaw RE; Stertzer SH; Hecht H; Ryan C; Cumberland D
    J Invasive Cardiol; 1993; 5(9):319-33. PubMed ID: 10146596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.